Correlation Between Neuropace and Accelerate Diagnostics
Can any of the company-specific risk be diversified away by investing in both Neuropace and Accelerate Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Accelerate Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Accelerate Diagnostics, you can compare the effects of market volatilities on Neuropace and Accelerate Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Accelerate Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Accelerate Diagnostics.
Diversification Opportunities for Neuropace and Accelerate Diagnostics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neuropace and Accelerate is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Accelerate Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accelerate Diagnostics and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Accelerate Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accelerate Diagnostics has no effect on the direction of Neuropace i.e., Neuropace and Accelerate Diagnostics go up and down completely randomly.
Pair Corralation between Neuropace and Accelerate Diagnostics
Given the investment horizon of 90 days Neuropace is expected to generate 2.53 times more return on investment than Accelerate Diagnostics. However, Neuropace is 2.53 times more volatile than Accelerate Diagnostics. It trades about 0.31 of its potential returns per unit of risk. Accelerate Diagnostics is currently generating about -0.18 per unit of risk. If you would invest 638.00 in Neuropace on August 29, 2024 and sell it today you would earn a total of 382.00 from holding Neuropace or generate 59.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Accelerate Diagnostics
Performance |
Timeline |
Neuropace |
Accelerate Diagnostics |
Neuropace and Accelerate Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Accelerate Diagnostics
The main advantage of trading using opposite Neuropace and Accelerate Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Accelerate Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will offset losses from the drop in Accelerate Diagnostics' long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Accelerate Diagnostics vs. CVRx Inc | Accelerate Diagnostics vs. Neuropace | Accelerate Diagnostics vs. Anika Therapeutics | Accelerate Diagnostics vs. Axogen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |